|
Volumn 151, Issue 1-2, 2004, Pages 6-11
|
In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-α converting enzyme attenuates seizures and injury of the cerebral cortex
|
Author keywords
Bacterial meningitis; Matrix metalloproteinases; Tumor necrosis factor alpha converting enzyme
|
Indexed keywords
CEFTRIAXONE;
COLLAGEN;
HYDROXYPROLINE;
MATRIX METALLOPROTEINASE;
MATRIX METALLOPROTEINASE INHIBITOR;
TNF 484;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;
TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;
UNCLASSIFIED DRUG;
WATER;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
BACTERIAL MENINGITIS;
BRAIN CORTEX;
BRAIN INJURY;
CEREBROSPINAL FLUID;
COLLAGEN DEGRADATION;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG EFFECT;
DRUG PENETRATION;
NEUROPROTECTION;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SEIZURE;
TREATMENT OUTCOME;
ADAM PROTEINS;
ANIMALS;
ANIMALS, NEWBORN;
APOPTOSIS;
CEREBRAL CORTEX;
DISEASE MODELS, ANIMAL;
ENZYME ACTIVATION;
ENZYME INHIBITORS;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
MATRIX METALLOPROTEINASES;
MENINGITIS, PNEUMOCOCCAL;
METALLOENDOPEPTIDASES;
RATS;
RATS, SPRAGUE-DAWLEY;
SEIZURES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 2442451453
PISSN: 01655728
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jneuroim.2004.01.026 Document Type: Article |
Times cited : (62)
|
References (25)
|